IQVIA Holdings IQV
$245.82 −$4.73 (-1.89%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $247.00 +0.48%
Open$250.55
Prev close$250.55
Day range$245.25 – $252.28
Volume1.25M
Market cap$40.51B
P/E (TTM)29.9
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$4.43B+8.0% YoY
Operating profit$608.00M+6.1% YoY
Net profit$352.00M+6.0% YoY
Diluted EPS$2.10+8.8% YoY
Free cash flow$667.00M-13.6% YoY
Operating cash flow$825.00M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin33.1%
Operating margin13.8%
Net margin8.1%
Return on equity21.7%
Return on assets4.7%
Return on invested capital9.1%
Current ratio0.83
Liabilities / assets77.7%
Cash & investments$2.42B
Total debt$16.31B
Net cash (debt)-$13.89B
Free cash flow / sales12.0%
Where the revenue comes from
Quarter 2026/Q3
By business line
SEC annual financial snapshot
Standard US-GAAP figures from 10-K filings in USD. Figures may reflect restatements. Checked 2026-11-22 14:51 UTC.
| Metric | USD | Basis | Period end | Filed / SEC source |
|---|---|---|---|---|
| Revenue | $16.31B | Annual | 2025-12-31 | 2026-02-17 |
| Net income | $1.36B | Annual | 2025-12-31 | 2026-02-17 |
| Operating cash flow | $2.65B | Annual | 2025-12-31 | 2026-02-17 |
| Total assets | $29.94B | Period end | 2025-12-31 | 2026-02-17 |
| Total liabilities | $23.31B | Period end | 2025-12-31 | 2026-02-17 |
| Stockholders’ equity | $6.50B | Period end | 2025-12-31 | 2026-02-17 |
| Cash and cash equivalents | $1.98B | Period end | 2025-12-31 | 2026-02-17 |
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $4.43B | $4.37B | $4.15B | $16.31B | $4.36B |
| Total Operating Revenue | $4.43B | $4.37B | $4.15B | $16.31B | $4.36B |
| Cost of Revenue | $2.93B | $2.93B | $2.80B | $10.88B | $2.93B |
| Gross Profit | $1.50B | $1.44B | $1.36B | $5.43B | $1.44B |
| Operating Expense | $890.00M | $866.00M | $790.00M | $3.14B | $785.00M |
| Selling and Admin Expenses | $569.00M | $574.00M | $502.00M | $2.00B | $468.00M |
| Depreciation & Amortization & Depletion | $321.00M | $292.00M | $288.00M | $1.14B | $317.00M |
| -Depreciation & Amortization | $321.00M | $292.00M | $288.00M | $1.14B | $317.00M |
| Operating Profit | $608.00M | $569.00M | $565.00M | $2.29B | $651.00M |
| Net Non-Operating Interest Income (Expense) | -$191.00M | -$190.00M | -$182.00M | -$684.00M | -$182.00M |
| Non-Operating Interest Income | $12.00M | $7.00M | $10.00M | $45.00M | $11.00M |
| Non-Operating Interest Expense | $203.00M | $197.00M | $192.00M | $729.00M | $193.00M |
| Other Income (Expense) | -$31.00M | -$78.00M | -$55.00M | -$12.00M | $68.00M |
| Special Income (Charges) | -$36.00M | -$66.00M | -$51.00M | -$111.00M | -$26.00M |
| -Less:Restructuring and Mergern & Acquisition | $36.00M | $63.00M | $51.00M | $105.00M | $24.00M |
| Other Non-Operating Income (Expenses) | $5.00M | -$12.00M | -$4.00M | $99.00M | $94.00M |
| Pretax Profit | $386.00M | $301.00M | $328.00M | $1.59B | $537.00M |
| Tax | $76.00M | $60.00M | $59.00M | $252.00M | $59.00M |
| -$42.00M | -$17.00M | -$6.00M | -$22.00M | -$36.00M | |
| Net Profit | $352.00M | $258.00M | $275.00M | $1.36B | $514.00M |
| Profit from Continuing Operations | $352.00M | $258.00M | $275.00M | $1.36B | $514.00M |
| Minority Interests | $2.00M | $2.00M | $1.00M | $1.00M | $0.00 |
| Net Income to Parent Company | $350.00M | $256.00M | $274.00M | $1.36B | $514.00M |
| Net Income to Common Stockholders | $350.00M | $256.00M | $274.00M | $1.36B | $514.00M |
| Basic EPS | $2.13 | $1.54 | $1.63 | $7.91 | $3.02 |
| Diluted EPS | $2.10 | $1.53 | $1.61 | $7.84 | $2.99 |
| -Less:Other Special Charges | – | $3.00M | – | $6.00M | $2.00M |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $30.47B | $29.88B | $29.68B | $29.94B | $29.94B |
| Total Current Assets | $6.45B | $6.23B | $6.22B | $6.25B | $6.25B |
| Cash and Cash Equivalents & Short-Term Investments | $2.42B | $2.08B | $2.10B | $2.14B | $2.14B |
| -Cash and Cash Equivalents | $2.25B | $1.91B | $1.95B | $1.98B | $1.98B |
| -Short Term Investments | $173.00M | $171.00M | $156.00M | $161.00M | $161.00M |
| Receivables | $3.33B | $3.39B | $3.38B | $3.43B | $3.43B |
| -Accounts Receivable | $1.60B | $1.63B | $1.63B | $1.67B | $1.67B |
| -Taxes Receivable | $39.00M | $42.00M | $29.00M | $27.00M | $27.00M |
| -Other Receivables | $1.74B | $1.77B | $1.76B | $1.78B | $1.78B |
| -Receivables Adjustments Allowances | -$52.00M | -$50.00M | -$49.00M | -$51.00M | -$51.00M |
| Prepaid Assets | $210.00M | $220.00M | $167.00M | $162.00M | $162.00M |
| Other Current Assets | $487.00M | $539.00M | $575.00M | $519.00M | $519.00M |
| Total Non-Current Assets | $24.02B | $23.66B | $23.46B | $23.70B | $23.70B |
| Net PPE | $847.00M | $851.00M | $809.00M | $823.00M | $823.00M |
| -Gross PPE | $847.00M | $851.00M | $809.00M | $1.73B | $1.73B |
| Investments and Advances | $524.00M | $472.00M | $452.00M | $432.00M | $432.00M |
| -Long Term Equity Investment | $438.00M | $390.00M | $357.00M | $324.00M | $324.00M |
| Goodwill and Other Intangible Assets | $21.64B | $21.35B | $21.35B | $21.58B | $21.58B |
| -Goodwill | $16.90B | $16.60B | $16.54B | $16.62B | $16.62B |
| -Other Intangible Assets | $4.74B | $4.75B | $4.80B | $4.96B | $4.96B |
| Non-Current Deferred Assets | $408.00M | $421.00M | $358.00M | $357.00M | $357.00M |
| Other Non-Current Assets | $606.00M | $558.00M | $489.00M | $505.00M | $505.00M |
| Total Liabilities | $23.68B | $23.58B | $23.33B | $23.31B | $23.31B |
| Total Current Liabilities | $7.78B | $8.82B | $8.33B | $8.34B | $8.34B |
| Payables | $3.85B | $3.78B | $3.81B | $920.00M | $920.00M |
| -Accounts Payable | $3.68B | $3.61B | $3.64B | $780.00M | $780.00M |
| -Total Tax Payable | $171.00M | $175.00M | $172.00M | $140.00M | $140.00M |
| Short-Term Debt and Capital Lease Obligation | $1.24B | $2.29B | $1.84B | $1.84B | $1.84B |
| -Current Debt | $1.24B | $2.29B | $1.84B | $1.84B | $1.84B |
| Current Deferred Liabilities | $2.31B | $2.28B | $2.26B | $2.12B | $2.12B |
| Other Current Liabilities | $373.00M | $457.00M | $413.00M | $489.00M | $489.00M |
| Total Non-Current Liabilities | $15.91B | $14.77B | $15.00B | $14.98B | $14.98B |
| Long Term Debt and Capital Lease Obligation | $15.07B | $13.95B | $14.22B | $14.11B | $14.11B |
| -Long Term Debt | $14.82B | $13.71B | $13.99B | $13.88B | $13.88B |
| -Long Term Capital Lease Obligation | $247.00M | $242.00M | $232.00M | $225.00M | $225.00M |
| Non-Current Deferred Liabilities | $157.00M | $173.00M | $159.00M | $179.00M | $179.00M |
| Other Non-Current Liabilities | $679.00M | $645.00M | $617.00M | $688.00M | $688.00M |
| Total Equity | $6.79B | $6.30B | $6.35B | $6.63B | $6.63B |
| Stockholders' Equity | $6.66B | $6.17B | $6.22B | $6.50B | $6.50B |
| Capital Stock | $3.00M | $3.00M | $3.00M | $3.00M | $3.00M |
| -Common Stock | $3.00M | $3.00M | $3.00M | $3.00M | $3.00M |
| Additional Paid-In Capital | $11.57B | $11.49B | $11.40B | $11.38B | $11.38B |
| Retained Earnings | $8.31B | $7.96B | $7.70B | $7.43B | $7.43B |
| Less: Treasury Stock | -$12.32B | -$12.32B | -$11.91B | -$11.36B | -$11.36B |
| Gains/Losses Not Affecting Retained Earnings | -$906.00M | -$964.00M | -$968.00M | -$943.00M | -$943.00M |
| Minority Interests | $131.00M | $130.00M | $128.00M | $127.00M | $127.00M |
| -Accumulated Depreciation | – | – | – | -$905.00M | -$905.00M |
| Current Accrued Expenses | – | – | – | $2.07B | $2.07B |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | $825.00M | $558.00M | $618.00M | $2.65B | $735.00M |
| Net cash flow from continuing operations | $825.00M | $558.00M | $618.00M | $2.65B | $735.00M |
| Net Income from Continuing Operations | $352.00M | $258.00M | $275.00M | $1.36B | $514.00M |
| Gain/Loss from Continuing Operations | -$47.00M | -$23.00M | $12.00M | -$66.00M | -$60.00M |
| Depreciation & Depletion & Amortization | $321.00M | $292.00M | $288.00M | $1.14B | $317.00M |
| Deferred Tax | -$23.00M | -$36.00M | -$38.00M | -$180.00M | -$48.00M |
| Other Non-Cash Items | $5.00M | $6.00M | $6.00M | $23.00M | $6.00M |
| Change in Working Capital | $134.00M | -$34.00M | $10.00M | $125.00M | -$54.00M |
| -Change in Receivables | $102.00M | $46.00M | $193.00M | $60.00M | -$382.00M |
| -Change In Other Working Capital | $32.00M | -$80.00M | -$183.00M | $242.00M | $505.00M |
| Net cash flow from investing | -$559.00M | -$381.00M | -$196.00M | -$2.31B | -$1.10B |
| Net Cash Flow from Continuing Investing Activities | -$559.00M | -$381.00M | -$196.00M | -$2.31B | -$1.10B |
| Net PPE Purchase and Sale | -$158.00M | -$198.00M | -$127.00M | -$528.00M | -$174.00M |
| Net Business Purchase and Sale | -$398.00M | -$186.00M | -$72.00M | -$1.76B | -$932.00M |
| Net Investment Purchase and Sale | $0.00 | $2.00M | $1.00M | -$18.00M | $0.00 |
| Financing Cash Flow | $78.00M | -$214.00M | -$433.00M | -$150.00M | $535.00M |
| Net Cash Flow from Continuing Financing Activities | $78.00M | -$214.00M | -$433.00M | -$150.00M | $535.00M |
| Net Issuance Payments Of Debt | $112.00M | $221.00M | $167.00M | $1.25B | $763.00M |
| Net Common Stock Issuance | $0.00 | -$398.00M | -$552.00M | -$1.24B | -$212.00M |
| Proceeds from Stock Option Exercised | -$2.00M | -$1.00M | -$40.00M | -$67.00M | -$1.00M |
| Net Other Financing Charges | -$32.00M | -$36.00M | -$8.00M | -$86.00M | -$15.00M |
| Ending Cash Balance | $2.25B | $1.91B | $1.95B | $1.98B | $1.98B |
| Net Change in Cash | $344.00M | -$37.00M | -$11.00M | $199.00M | $166.00M |
| Beginning Cash Balance | $1.91B | $1.95B | $1.98B | $1.70B | $1.81B |
| Effect of Exchange Rate Changes | -$4.00M | -$1.00M | -$22.00M | $79.00M | $0.00 |
| Free Cash Flow | $667.00M | $360.00M | $491.00M | $2.05B | $561.00M |
| Net Other Investing Changes | – | $1.00M | $2.00M | -$1.00M | $2.00M |
| -Change in Prepaid Assets | – | – | – | $218.00M | – |
| -Change in Payables and Accrued Expense | – | – | – | -$395.00M | – |
No comments yet — be the first to weigh in on IQV.
Sign in to join the discussion.